Mental Health Rising controversy over position of FDA and Medicare in selling anti-amyloid medicine given restricted profit, excessive value, extreme side-effects By / June 26, 2023
Medical News Alzheimer’s drug will get FDA panel’s backing, setting the stage for broader use By / June 10, 2023
